BIA
SAGE

Bell Investment Advisors’s Sage Therapeutics SAGE Stock Holding History

Bell Investment Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-107
Closed -$976 – 1954
2025
Q2 		$976 Hold
107
– – ﹤0.01% 1593
2025
Q1 		$851 Hold
107
– – ﹤0.01% 1605
2024
Q4 		$582 Buy
107
+89
+494% +$544 ﹤0.01% 1725
2024
Q3 		$130 Hold
18
– – ﹤0.01% 1865
2024
Q2 		$196 Hold
18
– – ﹤0.01% 1922
2024
Q1 		$338 Hold
18
– – ﹤0.01% 1880
2023
Q4 		$391 Hold
18
– – ﹤0.01% 1870
2023
Q3 		$371 Sell
18
-14
-44% -$404 ﹤0.01% 1874
2023
Q2 		$1.5K Hold
32
– – ﹤0.01% 1433
2023
Q1 		$1.34K Hold
32
– – ﹤0.01% 1444
2022
Q4 		$1.22K Hold
32
– – ﹤0.01% 1499
2022
Q3 		$1K Hold
32
– – ﹤0.01% 1555
2022
Q2 		$1K Buy
+32
New +$1.07K ﹤0.01% 1580
2021
Q4 		$1K Buy
35
+26
+289% +$1.09K ﹤0.01% 1587
2021
Q3 		$0 Buy
+9
New +$413 ﹤0.01% 1813

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Bell Investment Advisors's SAGE Position: Q3 2025 in Review

Bell Investment Advisors sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 107 shares — an estimated $976 sold.

Bell Investment Advisors first reported a position in SAGE in Q3 2021 and held it in 15 quarters. The position peaked at $1.5K in Q2 2023. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Bell Investment Advisors reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 107 Sage Therapeutics shares in Q3 2025, an estimated $976.
  • Bell Investment Advisors first reported a position in Sage Therapeutics in Q3 2021 and held it in 15 quarters.
  • Bell Investment Advisors's Sage Therapeutics position peaked at $1.5K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Bell Investment Advisors's 13F filing for Q3 2025, filed 21 Nov 2025.